Stock Detail
MERIDIAN BIOSCIENCE INC
Diagnostic Substances
VIVO @ Yahoo Finance | VIVO Option @ Yahoo Finance
Last Day's Data
| Current Price | High | Value Change | Percent Change | Dividend | Previous Close |
|---|---|---|---|---|---|
| $18.85 | $19.39 | $-0.50 | -2.58% | 0.76 | $19.35 |
| Opening Price | Low | Volume | Market Cap | Average Volume | P/E |
| $19.17 | $18.79 | 188,703 | 773.82M | 285,242 | 28.46 |
Pivot Table
| R2 | R1 | Pivot | S1 | S2 |
| 19.61 | 19.23 | 19.01 | 18.63 | 18.41 |
Stock Profile
Meridian Bioscience, Inc. operates as an integrated research, development, manufacturing, marketing, and sales organization in the field of life science. It develops, manufactures, and distributes diagnostic test kits primarily for respiratory, gastrointestinal, viral, and parasitic infectious diseases; and bulk antigens, antibodies, and reagents used by researchers and other diagnostic manufacturers, as well as provides contract manufacturing service of proteins and other biologicals for use by biopharmaceutical and biotechnology companies that are engaged in research for new drugs and vaccines. The company's product technologies include enzyme immunoassay, immunofluorescence, particle agglutination/aggregation, immunodiffusion, complement fixation, and chemical stains. It markets its products to hospitals, reference laboratories, research centers, veterinary testing centers, physician offices, and diagnostics manufacturers in approximately 60 countries worldwide, through direct sales force and independent distributors. The company was founded in 1976 and is based in Cincinnati, Ohio.